These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 20978715)

  • 1. Effects of Aggrenox and aspirin on plasma endothelial nitric oxide synthase and oxidised low-density lipoproteins in patients after ischaemic stroke. The AGgrenox versus aspirin therapy evaluation (AGATE) biomarker substudy.
    Serebruany V; Sani Y; Eisert C; Schevchuck A; Fong A; Hanley D
    Thromb Haemost; 2011 Jan; 105(1):81-7. PubMed ID: 20978715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial.
    Serebruany VL; Malinin AI; Sane DC; Jilma B; Takserman A; Atar D; Hennekens CH
    Eur J Pharmacol; 2004 Sep; 499(3):315-24. PubMed ID: 15381054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage?
    Serebruany VL; Malinin AI; Sane DC
    Am J Hematol; 2003 Apr; 72(4):280-1. PubMed ID: 12666142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnitude and time course of platelet inhibition with extended release dipyridamole with or without aspirin in healthy Japanese volunteers. The AGgrenox versus Aspirin Therapy Evaluation (AGATE-Japan).
    Serebruany VL; Malinin AI; Hanley DF
    Thromb Haemost; 2008 Jan; 99(1):116-20. PubMed ID: 18217142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipyridamole decreases protease-activated receptor and annexin-v binding on platelets of post stroke patients with aspirin nonresponsiveness.
    Serebruany V; Malinin A; Ziai W; Atar D; Pokov A; Jilma B; Hanley D
    Cerebrovasc Dis; 2006; 21(1-2):98-105. PubMed ID: 16340184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke.
    Zhao L; Gray L; Leonardi-Bee J; Weaver CS; Heptinstall S; Bath PM
    Platelets; 2006 Mar; 17(2):100-4. PubMed ID: 16421011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced ex vivo inhibition of platelet function following addition of dipyridamole to aspirin after transient ischaemic attack or ischaemic stroke: first results from the TRinity AntiPlatelet responsiveness (TrAP) study.
    Tobin WO; Kinsella JA; Collins DR; Coughlan T; O'Neill D; Egan B; Tierney S; Feeley TM; Murphy RP; McCabe DJ
    Br J Haematol; 2011 Mar; 152(5):640-7. PubMed ID: 21223254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of dipyridamole in blood components among post-stroke patients treated with extended release formulation.
    Serebruany V; Sabaeva E; Booze C; Atar OD; Eisert C; Hanley D;
    Thromb Haemost; 2009 Sep; 102(3):538-43. PubMed ID: 19718475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case-control study of the association between polymorphisms of the endothelial nitric oxide synthase and glycoprotein IIIa genes and upper gastrointestinal bleeding in users of low-dose aspirin.
    Piazuelo E; Fuentes J; García-González MA; Jiménez P; Lanas A
    Clin Ther; 2008 Jan; 30(1):121-30. PubMed ID: 18343248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Platelet function in patients with Alzheimer disease: analysis of 40 cases].
    Yu J; Jia JP
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(3):183-6. PubMed ID: 19537035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ellagic acid protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3K/Akt/eNOS pathway.
    Ou HC; Lee WJ; Lee SD; Huang CY; Chiu TH; Tsai KL; Hsu WC; Sheu WH
    Toxicol Appl Pharmacol; 2010 Oct; 248(2):134-43. PubMed ID: 20691200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Aggrenox (aspirin/dipyridamole) reduce the risk of recurrent stroke to a greater degree than aspirin alone?
    Hoover PL; Mold JW
    J Okla State Med Assoc; 2008 May; 101(5):80-2. PubMed ID: 18678202
    [No Abstract]   [Full Text] [Related]  

  • 15. Extended-release dipyridamole/aspirin.
    Hervey PS; Goa KL
    Drugs; 1999 Sep; 58(3):469-75; discussion 476-7. PubMed ID: 10493274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin potentiates human platelet eNOS activity without enhancing eNOS mRNA and protein levels.
    Yemisci M; Ay H; Kocaefe C; Qui J; Topalkara K; Ozgüç M; Kirazli S; Ozcebe O; Moskowitz MA; Dalkara T
    Cerebrovasc Dis; 2008; 26(2):190-8. PubMed ID: 18628618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic assessment of the secondary prevention of ischaemic stroke with dipyridamole plus aspirin (Aggrenox/Asasantin) in France.
    Marissal JP; Selke B
    Pharmacoeconomics; 2004; 22(10):661-70. PubMed ID: 15244491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of polymorphisms of endothelial nitric oxide synthase on ischemic stroke: a case-control study in a Chinese population.
    Cheng J; Liu J; Li X; Yu L; Peng J; Zhang R; Geng Y; Nie S
    Clin Chim Acta; 2008 Jun; 392(1-2):46-51. PubMed ID: 18396156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of HELP therapy on acute ischemic stroke and vascular endothelial cell function.
    Xue J; Dong Q; Han X; You H; Gu Y; Lin S
    Ther Apher Dial; 2007 Jun; 11(3):171-6. PubMed ID: 17497997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined dipyridamole and aspirin pellet formulation for improved oral drug delivery. Part 2: In-vivo evaluation and stability.
    Murtagh PW; Deasy PB
    J Microencapsul; 1996; 13(4):395-405. PubMed ID: 8808777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.